Statistics for Burosumab versus conventional therapy in children with X-linked hypophosphataemia: a randomised, active-controlled, open-label, phase 3 trial
Total visits
| views | |
|---|---|
| Burosumab versus conventional therapy in children with X-linked hypophosphataemia: a randomised, active-controlled, open-label, phase 3 trial | 167 |
Total visits per month
| views | |
|---|---|
| August 2024 | 0 |
| September 2024 | 0 |
| October 2024 | 0 |
| November 2024 | 0 |
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
File Visits
| views | |
|---|---|
| nihms-1563036.pdf | 279 |
| java.util.UUID:fe8e962e-30d9-4281-91bd-86ec50a1a49d | 91 |
| java.util.UUID:0af14c82-c9af-4e6d-adf1-dc41ae9c2543 | 17 |
| java.util.UUID:0a7b9a51-c6dd-4e05-9c66-902b45ce4799 | 10 |
Top country views
| views | |
|---|---|
| United States | 130 |
| China | 9 |
| Germany | 3 |
| Canada | 2 |
| Russia | 2 |
| Cyprus | 1 |
| Malaysia | 1 |
| Sweden | 1 |
| Ukraine | 1 |
Top city views
| views | |
|---|---|
| Wilmington | 42 |
| Jacksonville | 20 |
| Houston | 15 |
| Fairfield | 14 |
| Cambridge | 8 |
| Ling | 8 |
| Commack | 4 |
| Kiez | 2 |
| Moscow | 2 |
| Toronto | 2 |
| Ann Arbor | 1 |
| Baltimore | 1 |
| Chicago | 1 |
| Kiev | 1 |
| Lemesos | 1 |
| Nürnberg | 1 |
| Seattle | 1 |
| Seremban | 1 |
| Stockholm | 1 |
| Washington | 1 |